02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 67.05
+0.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 17.61x
- P/E 2027E
- 718.43x
- P/E 2028E
- 37.78x
- P/S forward
- 9.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.51x
- PEG TTM
- —
- Price / book
- 4.25x
- Price / sales
- 20.71x
- Price / cash flow
- -28.55x
Enterprise value
- Enterprise value
- HKD 17.0B
- EV / sales
- 17.62x
- EV / EBITDA
- -27.72x
- EV / EBIT
- -23.61x
- Market cap
- HKD 20.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026